Harnessing the power of Imaging Phenomics

We’re transforming the science of medical imaging. By harnessing the power of Imaging Phenomics we can improve current treatment, enhance diagnosis and accelerate development of next generation therapies, helping make a healthier world for millions.

 

Pushing the boundaries of imaging technology

We’re determined to push the boundaries of what imaging technology can achieve, to help develop next generation treatments with the potential to save or improve the lives of millions.

 

CEO’s message

Fredrik Brag talks about how we’re looking to change the game, to transform the landscape in which we work and create a new world of possibilities for biopharma companies and healthcare professionals alike. “Through its groundbreaking medical imaging solutions, Median Technologies is bringing imaging phenomics to Precision Medicine and patient care with high throughput cancer screening, more accurate diagnostics and individually targeted therapies. By directly focusing on the disease phenotype with imaging biomarkers, we allow the patient to benefit from the best adapted treatment with the least side effects […]”

Read more

The Imaging Phenomics Company®

Learn more about iSee®, our platform for the management of images in oncology clinical trials  and iBiopsy®, our imaging phenomics platform combining Artificial Intelligence, Cloud Computing and Big Data.

Watch

News

15 May 2019

Ongoing negotiations with the European Investment Bank to conclude a loan financing agreement including the issuance of Warrants (BSA)

This loan financing agreement will enable Median Technologies to accelerate its investment programs for its iBiopsy® imaging phenomics platform for the coming years

11 April 2019

Median Technologies Reports Full Year 2018 Financial Results

Median Technologies (Paris : ALMDT), The Imaging Phenomics Company® reported today full year 2018 financial results. Median Technologies Board of Directors approved the consolidated 2018 financial statements on April 10, 2019. The annual shareholders meeting will take place on June 26, 2019.

26 February 2019

Median Technologies to participate in the Cowen and Company 39th Annual Health Care Conference in Boston

Median Technologies, The Imaging Phenomics Company® (Paris: ALMDT), will be participating in the Cowen and Company 39th Annual Health Care Conference on Wednesday, March 13, 2019 in Boston. Fredrik Brag, Median’s Chairman, CEO and Co-founder will present at 9:20 am Eastern Time.

20 February 2019

Median Technologies to attend the 2019 European Congress of Radiology (ECR) from February 27 to March 3, 2019 in Vienna, Austria

Meet Median Technologies at Booth #AI-5, Expo X1, Artificial Intelligence Exhibition. Attend our iBiopsy® presentation scheduled for Feb. 28 at 1:40 pm CET, AI Theater, Expo X1 as well as our scientific presentation on image management in oncology trials (iCRO activities) scheduled for March 1st, from 10:30 to 12:00 am CET (Scientific Session 1016)

7 February 2019

Median Technologies Provides a Company Update and Announces Preliminary Full Year 2018 Unaudited Financial Results

Median Technologies announces preliminary and unaudited financial results for the full year 2018, a year of successful transition that has led to the reconfiguration of the company into two separate business units, iCRO and iBiopsy®, and to the realignment of its workforce and business activities with clarified strategic objectives.

1/5

Opinion

8 August 2018
New White Paper – Innovations in Cancer Screening

New White Paper – Innovations in Cancer Screening

New White Paper – Innovations in Cancer Screening There has been great progress in the diagnosis and treatment of cancer in recent years,…

10 July 2018
Demystifying How Images Are Managed

Demystifying How Images Are Managed

Demystifying How Images Are Managed Between February 2017 and January 2018, ~41.4 million diagnostic imaging tests were performed in England[i]. That so many…

18 June 2018
ASCO 2018: Headlines and Highlights

ASCO 2018: Headlines and Highlights

ASCO 2018: Headlines and Highlights All eyes were on the American Society of Clinical Oncology (ASCO) Annual conference last week in Chicago watching…

15 May 2018
Immunotherapy Update: Recent Advances in CAR T-cell Therapy

Immunotherapy Update: Recent Advances in CAR T-cell Therapy

Immunotherapy Update: Recent Advances in CAR T-cell Therapy As a measure of its promise, chimeric antigen receptor (CAR) T-cell therapy – where patients’…

14 March 2018
Industry Trends:  AI Revolutionizes Imaging Analysis

Industry Trends: AI Revolutionizes Imaging Analysis

Industry Trends:  AI Revolutionizes Imaging Analysis The radiology industry is embracing artificial intelligence (AI) to enhance image analysis, and it’s having a profound impact…

1/5
Imaging for clinical trials

Advancing treatments of the future

Working with biopharma companies and leading medical centers around the world, the team at Median enable researchers to identify disease fingerprints from medical images. We’re helping paving the way for new personalized and innovative medicines, more accurate and predictable diagnoses and better treatments.

Read more

Ibiopsy®

Powering the phenomics revolution

We’re changing the game, transforming the landscape. We’re capturing the power of big data, cloud computing and artificial intelligence to create a new world of possibilities for biopharma compannies and healthcare professionals alike. Our iBiopsy® platform opens up the field of phenomics, driving the science of precision and predictive medicine.

Read more

Investors

Delivering value

Our technology and expertise is creating a new world of possibilities for biopharmaceutical and healthcare professionals around the world. By successfully helping improve the lives of millions, we are also delivering value for our investors and partners.

Read more

Stock Market Data

TICKER: ALMDT ISIN: FR0011049824
Get in touch
Europe
United States
China

china

12/F Platinum Tower 233 Tai Cang Road Shanghai 200020 China

europe

Median Technologies Les Deux Arcs, Bât B 1800, route des Crêtes 06560 Valbonne France

United States

Legal address Median Technologies Inc C/O Pramex International 1251 Avenue of the Americas 3rd Floor New York NY 10020 US offices

Median Technologies Inc 300 TradeCenter Suite 5610 Woburn MA 01801

Get in touch

Get in touch





Jobs at Median

Cookies help us deliver our services. By using our services, you agree to our use of cookies.